Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12345 Next »
Viewing Page 1 of 5 | Showing Results 1 - 5 of 25

Multicenter 1-year Observational Study of Patients who are Initiating Brivaracetam

The purpose of this study is to examine how often brivaracetam treatment continues at 12 months, and the reasons why the drug was stopped (if...

Evan Fertig, M.D.
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center

A 12-Month Open-Label, Repeat-Dose Safety Study of NRL-1 in Epilepsy Subjects (DIAZ.001.05)

This is a 12 month safety study to evaluate the safety of repeated doses of NRL-1. Key Eligibilities: -Subject has a clinical diagnosis of...

Evan Fertig, M.D.
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center

Measurement of Relaxin in the Serum and Cerebrospinal Fluid of Subjects With and Without the Relapsing Form of Multiple Sclerosis

This study will evaluate relaxin (RLX) levels in patients with multiple sclerosis. Key Eligibilities: -Females 18 to 45 years of age. -Patients...

Stanley Cohan, M.D., Ph.D.
  • Providence St. Vincent Medical Center

BIP - The Effect of ACTH (Acthar®) on Measures of Chronic Fatigue in Patients with Relapsing Multiple Sclerosis

This is a study of Acthar gel (ACTH) in patients with relapsing multiple sclerosis who are experiencing chronic fatigue. Key Eligibilities: -Have...

Stanley Cohan, M.D., Ph.D.
  • MultiCare Health System
  • North Central Neurology Associates, PC
  • Providence St. Vincent Medical Center
  • Rocky Mountain Research Group

BIP - Long-term, Prospective, Multinational, Parallel-cohort Study Monitoring Safety in Patients With MS Newly Started With Fingolimod Once Daily or Treated With Another Approved Disease-modifying Therapy

The purpose of this world-wide prospective parallel-cohort study in patients with relapsing forms of Multiple Sclerosis, either newly treated with...

Stanley Cohan, M.D., Ph.D.
  • Providence St. Vincent Medical Center
« Previous 12345 Next »
Viewing Page 1 of 5 | Showing Results 1 - 5 of 25